• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.腺病毒 5 型和改良安卡拉牛痘病毒疫苗诱导的 HIV-1 Gag 特异性 CD8 T 细胞的扩增、收缩和记忆分化的不同模式。
Vaccine. 2011 Jul 26;29(33):5399-406. doi: 10.1016/j.vaccine.2011.05.083. Epub 2011 Jun 7.
2
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.用异源DNA初免-改良安卡拉痘苗病毒加强的HIV-1疫苗方案接种后对保守的Gag区域的优先靶向作用
J Virol. 2017 Aug 24;91(18). doi: 10.1128/JVI.00730-17. Print 2017 Sep 15.
3
Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.采用初免-加强方案的丙型肝炎病毒T细胞疫苗引发的细胞免疫原性的定性差异。
PLoS One. 2017 Jul 21;12(7):e0181578. doi: 10.1371/journal.pone.0181578. eCollection 2017.
4
A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.一种多基因1型人类免疫缺陷病毒C亚型改良安卡拉痘苗(MVA)疫苗可有效增强小鼠对DNA疫苗的免疫反应。
AIDS Res Hum Retroviruses. 2008 Feb;24(2):207-17. doi: 10.1089/aid.2007.0206.
5
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.通过基因互补策略扩大基于安卡拉痘苗病毒的改良疫苗载体的种类。
PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.
6
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.表达1型人类免疫缺陷病毒gag基因的DNA质粒、重组痘苗病毒和复制缺陷型腺病毒载体在恒河猴中的免疫原性比较
J Virol. 2003 Jun;77(11):6305-13. doi: 10.1128/jvi.77.11.6305-6313.2003.
7
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.通过删除阻断干扰素信号通路的痘苗病毒基因(C6L和K7R)来改善HIV/AIDS候选疫苗MVA-B的适应性免疫和记忆免疫反应
PLoS One. 2013 Jun 27;8(6):e66894. doi: 10.1371/journal.pone.0066894. Print 2013.
8
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.缺失编码 IRF3 抑制剂的牛痘病毒 N2L 基因可提高表达 HIV-1 抗原的改良安卡拉牛痘病毒的免疫原性。
J Virol. 2014 Mar;88(6):3392-410. doi: 10.1128/JVI.02723-13. Epub 2014 Jan 3.
9
Comparative analysis of simian immunodeficiency virus gag-specific effector and memory CD8+ T cells induced by different adenovirus vectors.比较不同腺病毒载体诱导的猴免疫缺陷病毒 gag 特异性效应和记忆 CD8+T 细胞。
J Virol. 2013 Feb;87(3):1359-72. doi: 10.1128/JVI.02055-12. Epub 2012 Nov 21.
10
T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load.重组黑猩猩腺病毒单独诱导和加强免疫方案诱导的 T 细胞可降低嵌合 EcoHIV/NDK 挑战病毒载量。
Eur J Immunol. 2012 Dec;42(12):3243-55. doi: 10.1002/eji.201242624. Epub 2012 Oct 16.

引用本文的文献

1
Lentiviral vector induces high-quality memory T cells via dendritic cells transduction.慢病毒载体通过树突状细胞转导诱导高质量的记忆 T 细胞。
Commun Biol. 2021 Jun 10;4(1):713. doi: 10.1038/s42003-021-02251-6.
2
Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4/CD8 T cells and humoral responses in macaques.黏膜 IL-4R 拮抗剂 HIV 疫苗接种联合 SOSIP-gp140 增强剂可诱导猕猴产生高质量的细胞毒性 CD4/CD8 T 细胞和体液应答。
Sci Rep. 2020 Dec 16;10(1):22077. doi: 10.1038/s41598-020-79172-7.
3
Novel Concepts for HIV Vaccine Vector Design.HIV疫苗载体设计的新概念
mSphere. 2017 Dec 6;2(6). doi: 10.1128/mSphere.00415-17. eCollection 2017 Nov-Dec.
4
Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues.疫苗接种的机体水平分析揭示了跨组织的保护网络。
Cell. 2017 Oct 5;171(2):398-413.e21. doi: 10.1016/j.cell.2017.08.024. Epub 2017 Sep 21.
5
Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization.腺病毒载体免疫后记忆性CD8 T细胞上抑制性受体的表达。
Vaccine. 2016 Sep 22;34(41):4955-4963. doi: 10.1016/j.vaccine.2016.08.048. Epub 2016 Aug 24.
6
Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.腺病毒疫苗和痘苗病毒安卡拉疫苗对T细胞反应广度和层次的影响。
Vaccine. 2016 Aug 31;34(38):4470-4474. doi: 10.1016/j.vaccine.2016.07.050. Epub 2016 Jul 30.
7
Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques.使用重组黑猩猩腺病毒载体和佐剂化F4蛋白的异源初免-加强免疫方案在猕猴中引发多功能HIV-1特异性T细胞反应。
PLoS One. 2015 Apr 9;10(4):e0122835. doi: 10.1371/journal.pone.0122835. eCollection 2015.
8
Evaluation of non-reciprocal heterologous immunity between unrelated viruses.评估不相关病毒之间的非互惠异源免疫。
Virology. 2015 Aug;482:89-97. doi: 10.1016/j.virol.2015.03.002. Epub 2015 Mar 31.
9
Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.用甲病毒复制子进行初次免疫以及同源或异源加强免疫后CD8 + T细胞反应的动力学和表型分析。
J Virol. 2014 Nov;88(21):12438-51. doi: 10.1128/JVI.02223-14. Epub 2014 Aug 13.
10
Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS.针对 gp120 和 PD-1 的抗体在病毒特异性 CD8+ T 细胞中的表达可预防猴艾滋病。
J Virol. 2013 Mar;87(6):3526-37. doi: 10.1128/JVI.02686-12. Epub 2013 Jan 16.

本文引用的文献

1
Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.腺病毒 5 型在树突状细胞中诱导维生素 A 代谢酶,并增强肠道归巢 CD8 T 细胞的启动。
Mucosal Immunol. 2011 Sep;4(5):528-38. doi: 10.1038/mi.2011.1. Epub 2011 Feb 2.
2
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.基于T细胞的疫苗对恒河猴SIV攻击的免疫控制。
Nature. 2009 Jan 1;457(7225):87-91. doi: 10.1038/nature07469. Epub 2008 Nov 9.
3
Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation.刺激强度和克隆竞争影响记忆性CD8 T细胞分化的速率。
J Immunol. 2007 Nov 15;179(10):6704-14. doi: 10.4049/jimmunol.179.10.6704.
4
Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.1型人类免疫缺陷病毒控制者而非非控制者可维持共表达三种细胞因子的CD4 T细胞。
J Virol. 2007 Nov;81(21):12071-6. doi: 10.1128/JVI.01261-07. Epub 2007 Aug 29.
5
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.多功能TH1细胞确定了疫苗介导的针对硕大利什曼原虫的保护作用的一个相关因素。
Nat Med. 2007 Jul;13(7):843-50. doi: 10.1038/nm1592. Epub 2007 Jun 10.
6
Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.初始T细胞受体转基因细胞前体频率决定了CD8(+) T细胞对感染反应的关键方面。
Immunity. 2007 Jun;26(6):827-41. doi: 10.1016/j.immuni.2007.04.013. Epub 2007 Jun 7.
7
Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.产生多种细胞因子的抗病毒 CD4 T 细胞在功能上优于产生单一细胞因子的细胞。
J Virol. 2007 Aug;81(16):8468-76. doi: 10.1128/JVI.00228-07. Epub 2007 Jun 6.
8
Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.腺病毒载体在体内持续存在并维持活化的CD8+ T细胞:对其作为疫苗使用的启示。
Blood. 2007 Sep 15;110(6):1916-23. doi: 10.1182/blood-2007-02-062117. Epub 2007 May 17.
9
DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.DNA/MVA HIV-1/艾滋病疫苗可引发持久的痘苗病毒特异性免疫,并对致死性猴痘攻击提供保护。
Virology. 2007 Sep 15;366(1):73-83. doi: 10.1016/j.virol.2007.04.010. Epub 2007 May 16.
10
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.六邻体嵌合5型腺病毒载体可规避预先存在的抗载体免疫。
Nature. 2006 May 11;441(7090):239-43. doi: 10.1038/nature04721. Epub 2006 Apr 16.

腺病毒 5 型和改良安卡拉牛痘病毒疫苗诱导的 HIV-1 Gag 特异性 CD8 T 细胞的扩增、收缩和记忆分化的不同模式。

Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.

机构信息

Vaccine Research Center, Department of Microbiology and Immunology, Yerkes National Primate Research Center and Emory University School of Medicine, Emory University, 954 Gatewood Road NE, Atlanta, GA 30329, USA.

出版信息

Vaccine. 2011 Jul 26;29(33):5399-406. doi: 10.1016/j.vaccine.2011.05.083. Epub 2011 Jun 7.

DOI:10.1016/j.vaccine.2011.05.083
PMID:21651938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3139022/
Abstract

The magnitude and functional quality of antiviral CD8 T cell responses are critical for the efficacy of T cell based vaccines. Here, we investigate the influence of two popular viral vectors, adenovirus type 5 (Ad5) and modified vaccinia Ankara (MVA), on expansion, contraction and memory differentiation of HIV-1 Gag insert-specific CD8 T cell responses following immunization and show different patterns for the two recombinant viral vectors. The Ad5 vector primed 6-fold higher levels of insert-specific CD8 effector T cells than the MVA vector. The Ad5-primed effector cells also underwent less contraction (<2-fold) than the MVA-primed cells (>5-fold). The Ad5-primed memory cells were predominantly CD62L negative (effector memory) whereas the MVA-primed memory cells were predominantly CD62L positive (central memory). Consistent with their memory phenotype, MVA-primed CD8 T cells underwent higher fold expansion than Ad5-primed CD8 T cells following a homologous or heterologous boost. Impressively, the Ad5 boost changed the quality of MVA-primed memory response such that they undergo less contraction with effector memory phenotype. However, the MVA boost did not influence the contraction and memory phenotype of Ad5-primed response. In conclusion, our results demonstrate that vaccine vector strongly influences the expansion, contraction and the functional quality of insert-specific CD8 T cell responses and have implications for vaccine development against infectious diseases.

摘要

抗病毒 CD8 T 细胞反应的幅度和功能质量对于基于 T 细胞的疫苗的疗效至关重要。在这里,我们研究了两种流行的病毒载体,腺病毒 5 型(Ad5)和改良安卡拉牛痘(MVA),对免疫接种后 HIV-1 Gag 插入物特异性 CD8 T 细胞反应的扩增、收缩和记忆分化的影响,并显示出两种重组病毒载体的不同模式。Ad5 载体引发的插入物特异性 CD8 效应 T 细胞水平比 MVA 载体高 6 倍。Ad5 引发的效应细胞收缩程度也低于 MVA 引发的细胞(<2 倍)(>5 倍)。Ad5 引发的记忆细胞主要为 CD62L 阴性(效应记忆),而 MVA 引发的记忆细胞主要为 CD62L 阳性(中央记忆)。与它们的记忆表型一致,MVA 引发的 CD8 T 细胞在同源或异源增强后经历了比 Ad5 引发的 CD8 T 细胞更高的倍数扩增。令人印象深刻的是,Ad5 增强改变了 MVA 引发的记忆反应的质量,使它们具有更少的收缩和效应记忆表型。然而,MVA 增强并不影响 Ad5 引发的反应的收缩和记忆表型。总之,我们的结果表明,疫苗载体强烈影响插入物特异性 CD8 T 细胞反应的扩增、收缩和功能质量,这对传染病疫苗的开发具有重要意义。